Logo
x

Search

Subscribe Now

Thermo Fisher

PharmaShots' Key Highlights of First Quarter 2023

PharmaShots' Key Highlights of First Quarter 2023

  • April 3, 2023
Thermo Fisher and AstraZeneca Enters into Multiyear Agreement to Develop Companion Diagnostic Test

Thermo Fisher and AstraZeneca Enters into Multiyear Agreement to Develop Companion Diagnostic Test

  • January 25, 2023
Thermo Fisher Reports Completion of Acquisition of The Binding Site at ~$2.8B

Thermo Fisher Reports Completion of Acquisition of The Binding Site at ~$2.8B

  • January 4, 2023
Kindra Whitlatch, Product Applications Manager at ThermoFisher Scientific, Shares Insights on Drug Stability Testing

Kindra Whitlatch, Product Applications Manager at ThermoFisher Scientific, Shares Insights on Drug Stability Testing

  • September 26, 2022
PharmaShots Interview: Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients with NSCLC at ASCO 2022

PharmaShots Interview: Kathy Davy, VP of Oncology at Thermo Fisher Scientific Shares Insights on the Real-World Data from Patients...

  • July 20, 2022
Thermo Fisher’s Oncomine Dx Target Test Receives the US FDA's Approval as a NGS-Based CDx for the Treatment of NSCLC

Thermo Fisher’s Oncomine Dx Target Test Receives the US FDA's Approval as a NGS-Based CDx for the Treatment of NSCLC

  • December 10, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.